Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 29;10(23):10652–10664. doi: 10.7150/thno.47933

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Therapeutic efficacy of scaffolds. (A) Visible light images and in vivo fluorescence images of nude mice after 30 days of treatment. (B) Photographs of recurrent tumors and lungs after 30 days of treatment. (C) H&E staining of recurrent tumors, hearts, and lungs (the blue dotted frames indicate the tumor lesions). (D) Immunohistochemical analysis of sections of recurrent tumor stained with anti-Caspase-3 and anti-Ki67 antibodies. (E) Changes in body weight and (F) growth of recurrent tumor during various treatments. (G) Postoperative recurrence rate and (H) survival curve of mice during various treatments. *P < 0.05.